Combination of levofloxacin and cisplatin enhances anticancer efficacy via co-regulation of eight cancer-associated genes

Chemosensitizer or combined chemotherapy can sensitize cancer cells to therapy and minimize drug resistance. We reveal that levofloxacin has broad-spectrum anticancer activity. Here we report that combination of levofloxacin and cisplatin further enhanced cytotoxicity in cancer cells by further prom...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Xiaoqiong, Yao, ·Qian, Fan, Dan, You, Yutong, Lian, Wenjing, Zhou, Zhangping, Duan, Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9391551/
https://www.ncbi.nlm.nih.gov/pubmed/35984577
http://dx.doi.org/10.1007/s12672-022-00541-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9391551/
https://www.ncbi.nlm.nih.gov/pubmed/35984577
http://dx.doi.org/10.1007/s12672-022-00541-x

Ejemplares similares